Bo Shen, MD
Cleveland Clinic
Cleveland , OH

Bo Shen, MD, is a Staff Member of the Department of Gastroenterology and Hepatology, Professor of Medicine and the Ed Joey Story Endowed Chair, the Cleveland Clinic Foundation. His specialty interests include inflammatory bowel disease (IBD), , pouchitis and pouch diseases, and endoscopic management of IBD.

Dr. Shen earned his medical degree from Nantong Medical College in Jiangsu, China. He completed an internship and residency in internal medicine at Nantong Medical College Hospital in China, a residency in internal medicine at University of Illinois at Urbana-Champaign in Urbana, Ill. He also completed GI fellowship and Advance Endoscopy Fellowship at the Department of Gastroenterology at the Cleveland Clinic in Cleveland, Ohio.

He has been certified by the American Board of Internal Medicine, as well as a specialized certification in Gastroenterology.

He has secured grants for multiple research projects in IBD and ileal pouch disorders, from the National Institutes of Health (NIH), American College of Gastroenterology, Crohn’s and Colitis Foundation of America, American Gastroenterology Association, American Society for Gastrointestinal Endoscopy, and Broad Foundation.

Dr. Shen is a physician member of the Crohn’s and Colitis Foundation of America, and fellow of American Gastroenterological Association (AGAF), the American Society for Gastrointestinal Endocscopy (FASGE) and the American College of Gastroenterology (FACG) specialized certification in gastroenterology.

Gastroenterologists and hepatologists at Cleveland Clinic offer expert diagnosis and medical treatment for patients with disorders of the esophagus, liver, gallbladder, stomach, pancreas, small intestine and colon.

Diseases and Disorders We Treat
Cleveland Clinic Gastroenterology offers comprehensive treatment for many disorders including:
• Bile Duct Diseases
• Disorders of the Colon and Rectum
• Disorders of the Small Bowel
• Esophageal Disorders
• Liver Diseases
• Pancreas Disorders
• Stomach Diseases

Treatment Options and Services
Cleveland Clinic Gastroenterologists use the latest endoscopic advances to perform tens of thousands of minimally invasive procedures each year. These include colonoscopy, sigmoidoscopy and state-of-the-art procedures such as capsule endoscopy, endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP).

Other innovative treatments options and procedures include:
• Cryoablation for Barrett’s Esophagus
• Endoscopic Pancreatic Function Test
• Extracorporeal and intraductal Lithotripsy
• Endoscopy Therapy for IBD and ileal pouch disorders

Why You Should Choose Us
The Digestive Disease Institute is ranked #2 in the country by U.S.News & World Report 2008 “America’s Best Hospitals” survey.

With the experience of our physicians and nurses, minimally invasive procedures are performed efficiently and safely, with complication rates at or below national averages. Hepatologists attract patients from across the country with their expertise in treating patients with a wide range of common and uncommon liver diseases, including viral hepatitis, fatty liver, alcoholic liver disease, cholestatic liver diseases, inherited liver diseases and liver cancer.

Success Rates
Gastroenterologists perform nearly 28,000 endoscopic procedures annually and read more endoscopic capsule videos than any other academic medical center in the nation.

The Center for Swallowing and Esophageal Disorders maintains the largest non-VA hospital registry in the United States and treats more than 800 patients with Barrett’s Esophagus.

Our Staff
Due to our innovative therapies, participation in clinical trials and excellent surgical outcomes, the Department of Gastroenterology and Hepatology receives worldwide referrals, particularly for complex cases and severely affected patients.

Contact the Gastroenterology department:
Ph. 216.444.6536 or toll-free 800.223.2273 (ext. 4-6536).

 Diversity and potential application of endophytic bacteria in ginger.

 Comparison of different surgical approaches of functional endoscopic sinus surgery on patients with chronic rhinosinusitis.

 Association between gastro-intestinal symptoms and menstruation in patients with ileal pouches.

 Clostridium difficile infection in patients with ileal pouches.

 GM-CSF facilitates the development of inflammation-associated colorectal carcinoma.

 Comparison of long-term outcomes of S and J pouches and continent ileostomies in ulcerative colitis patients with restorative proctocolectomy-experience in subspecialty pouch center.

 Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis

The purpose of this study is to evaluate the safety and effectiveness of trichuris suis ova (TSO) in ulcerative colitis (UC). We will look at how TSO affects the body's immune response and if there are related changes in participants' UC.

The cause of UC is not well understood. It is believed to be caused from an abnormal immune response to the normal bacteria that live in the gut (intestines and colon). This response acts as an "attack" on the healthy tissue of the bowel by a person's own immune cells which leads to disease.

It is well known that autoimmune diseases such as IBD, asthma, diabetes, and multiple sclerosis are more common in industrialized, well-developed countries with better sanitation and hygiene, as in the United States. These "cleaner" environments reduce exposure to germs and parasites naturally found in the environment. This reduced exposure may trigger responses in the body that make people more prone to diseases such as UC. People in non-industrialized countries and the tropics, where parasites are common, rarely develop these diseases. This observation has led researchers to want to better understand the relationship between the lack of natural bacteria in the gut and the onset of autoimmune diseases like as UC.

Estimated Enrollment: 120
Study Start Date: November 2013
Estimated Study Completion Date: September 2016
Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)

    Webcasts

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (ENGLISH)

    James Lindsay, MD, Peter Irving, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (FRENCH)

    Philippe Marteau, MD, Jean-Frederic Colombel, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (GERMAN)

    Stefan Schreiber, MD, Daniel C. Baumgart, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (SPANISH)

    Yago González Lama, MD, Julian Panes, MD

    Didactic Lecture

    view details >

    Mechanistic Approaches to IBD: Current & Future Management Strategies

    Stephen B. Hanauer, MD (chair), Gary R. Lichtenstein, MD, David G. Binion, MD, William Sandborn, MD, Corey A. Siegel, MD

    Didactic Lecture

    view details >

    Precision Medicine & Novel Therapeutics

    Maria T. Abreu, MD, David G. Binion, MD, Stephen B. Hanauer, MD, Gary R. Lichtenstein, MD, Eduardo V. Loftus JR., MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2015: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Update on IBD

    Raymond Cross, MD

    Didactic Lecture

    view details >

    Optimizing Therapies for Severe Ulcerative Colitis

    Ellen Scherl, MD

    Didactic Lecture

    view details >

    Epidemiology of IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW - Reporting on IBD

    Maria T. Abreu, MD, Stephen B. Hanauer, MD, Scot Plevy, MD

    Didactic Lecture

    view details >

    eMonograph

    Expert Perspectives in the Management of Inflammatory Bowel Disease (IBD): A Review of Recent Advances

    view details >

    Advances in IBD

    view details >

    Optimizing the Management of Inflammatory Bowel Disease

    view details >

    Webcasts

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (ENGLISH)

    James Lindsay, MD, Peter Irving, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (FRENCH)

    Philippe Marteau, MD, Jean-Frederic Colombel, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (GERMAN)

    Stefan Schreiber, MD, Daniel C. Baumgart, MD

    Didactic Lecture

    view details >

    2016-2017 XPERT PERSPECTIVES ON ULCERATIVE COLITIS IN EUROPE (SPANISH)

    Yago González Lama, MD, Julian Panes, MD

    Didactic Lecture

    view details >

    Mechanistic Approaches to IBD: Current & Future Management Strategies

    Stephen B. Hanauer, MD (chair), Gary R. Lichtenstein, MD, David G. Binion, MD, William Sandborn, MD, Corey A. Siegel, MD

    Didactic Lecture

    view details >

    Precision Medicine & Novel Therapeutics

    Maria T. Abreu, MD, David G. Binion, MD, Stephen B. Hanauer, MD, Gary R. Lichtenstein, MD, Eduardo V. Loftus JR., MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW 2015: Reporting on IBD

    Stephen Hanauer, MD, Maria Abreu, MD, Gary Lichtenstein, MD

    Didactic Lecture

    view details >

    Update on IBD

    Raymond Cross, MD

    Didactic Lecture

    view details >

    Optimizing Therapies for Severe Ulcerative Colitis

    Ellen Scherl, MD

    Didactic Lecture

    view details >

    Epidemiology of IBD

    Edward Loftus, MD

    Didactic Lecture

    view details >

    Xpert Perspectives from DDW - Reporting on IBD

    Maria T. Abreu, MD, Stephen B. Hanauer, MD, Scot Plevy, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2017 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.